Get the Stockscreener App
42.41
0.31%
+0.13
After Hours:
42.395
-0.015
-0.04%
Taro Pharmaceutical Industries Stock (TARO) Forecast
The Taro Pharmaceutical Industries (TARO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $28.47, representing a -32.88% decrease from the current price of $42.41. The highest analyst price target is $29.76, and the lowest is $27.17.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TARO Price Target
Average 38.18
(-9.97% Downside)
Is Taro Pharmaceutical Industries (TARO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.04 | Neutral |
| STOCH(9,6) | 58.64 | Neutral |
| STOCHRSI(14) | 44.03 | Neutral |
| MACD(12,26) | 0.0687 | Sell |
| ADX(14) | 14.33 | Neutral |
| William %R | -45.31 | Neutral |
| CCI(14) | 1.0825 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
42.43
Sell
|
42.39
Buy
|
| MA20 |
42.32
Buy
|
42.34
Buy
|
| MA50 |
42.18
Buy
|
42.15
Buy
|
| MA100 |
42.13
Buy
|
41.40
Buy
|
| MA200 |
39.43
Buy
|
39.15
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, TARO could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 2 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on TARO, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 54.04 indicates that TARO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 58.64 indicates that TARO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 44.03 indicates that TARO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.33 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 1.0825 indicates that TARO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TARO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Taro Pharmaceutical Industries financial reports and earnings history, Taro Pharmaceutical Industries (TARO) stock could reach $55.48 by 2030, $84.03 by 2040 and $106.97 by 2050. See the projected annual prices until 2050 of the Taro Pharmaceutical Industries stock below:
- Taro Pharmaceutical Industries (TARO) is expected to reach an average price of $56.72 in 2035, with a high prediction of $56.79 and a low estimate of $53.20. This indicates an $33.74% rise from the last recorded price of $42.41.
- Taro Pharmaceutical Industries (TARO) stock is projected to chart a bullish course in 2040, with an average price target of $83.68, representing an $97.30% surge from its current level. The forecast ranges from a conservative $81.94 to a sky-high $84.03.
- Our analysts predict Taro Pharmaceutical Industries (TARO) to jump 128.32% by 2045, soaring from $90.34 to an average price of $96.83, potentially reaching $97.92. While $90.34 is the low estimate, the potential upside is significant.
- Taro Pharmaceutical Industries (TARO) stock is expected to climb by 2050, reaching an average of $104.98, a $147.55% jump from its current level. However, a wide range of estimates exists, with high and low targets of $106.97 and $104.01, respectively, highlighting the market's uncertainty.
Taro Pharmaceutical Industries Stock (TARO) Year by Year Forecast
Taro Pharmaceutical Industries Stock (TARO) Price Forecast for 2024
Our forecast for TARO stock price in 2024 now indicates an average price target of $35.95 with a high forecast of $45.76 and a low forecast of $26.13. The average prediction reflects an decrease of -15.24% from the last recorded price of $42.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $28.46 | $27.17 | $29.76 | -32.90% |
| July, 2024 | $40.19 | $27.95 | $40.62 | -5.24% |
| August, 2024 | $42.06 | $40.28 | $45.51 | -0.82% |
| September, 2024 | $41.31 | $39.50 | $42.82 | -2.60% |
| October, 2024 | $40.46 | $38.61 | $42.23 | -4.61% |
| November, 2024 | $41.22 | $40.35 | $44.13 | -2.80% |
| December, 2024 | $39.49 | $39.41 | $42.58 | -6.89% |
Taro Pharmaceutical Industries Stock (TARO) Price Forecast for 2025
Taro Pharmaceutical Industries Stock (TARO) is expected to reach an average price of $39.28 in 2025, with a high prediction of $49.19 and a low estimate of $29.37. This indicates an -7.38% fall from the last recorded price of $42.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $38.38 | $36.04 | $41.01 | -9.51% |
| February, 2025 | $39.39 | $37.26 | $40.39 | -7.12% |
| March, 2025 | $45.72 | $39.40 | $46.81 | +7.80% |
| April, 2025 | $46.71 | $44.09 | $49.19 | +10.13% |
| May, 2025 | $45.62 | $45.62 | $47.21 | +7.57% |
| June, 2025 | $45.49 | $43.91 | $45.74 | +7.26% |
| July, 2025 | $45.52 | $45.33 | $45.96 | +7.33% |
| August, 2025 | $45.84 | $45.51 | $46.16 | +8.08% |
| September, 2025 | $30.80 | $29.37 | $45.88 | -27.37% |
| October, 2025 | $33.89 | $30.43 | $33.96 | -20.09% |
| November, 2025 | $43.46 | $33.90 | $43.89 | +2.48% |
| December, 2025 | $44.52 | $43.56 | $48.80 | +4.98% |
Taro Pharmaceutical Industries Stock (TARO) Price Forecast for 2026
The predicted value for Taro Pharmaceutical Industries (TARO) in 2026 is set at an average of $46.01. Estimates vary from a peak of $52.61 to a trough of $39.41, indicating an +8.49% surge from the present price of $42.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $43.32 | $42.80 | $45.54 | +2.15% |
| February, 2026 | $43.78 | $41.94 | $44.89 | +3.24% |
| March, 2026 | $44.56 | $43.68 | $47.47 | +5.08% |
| April, 2026 | $41.50 | $41.22 | $45.93 | -2.14% |
| May, 2026 | $41.75 | $39.41 | $42.45 | -1.55% |
| June, 2026 | $42.78 | $40.64 | $43.78 | +0.88% |
| July, 2026 | $48.60 | $42.79 | $50.22 | +14.60% |
| August, 2026 | $50.13 | $47.52 | $52.61 | +18.21% |
| September, 2026 | $48.95 | $48.89 | $50.64 | +15.43% |
| October, 2026 | $49.06 | $47.37 | $49.15 | +15.69% |
| November, 2026 | $48.99 | $48.80 | $49.44 | +15.53% |
| December, 2026 | $48.85 | $48.10 | $49.66 | +15.19% |
Taro Pharmaceutical Industries Stock (TARO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Taro Pharmaceutical Industries (TARO) is $44.33, with a high forecast of $56.04 and a low forecast of $32.61. This indicates an +4.52% increase from the last price of $42.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $34.07 | $32.61 | $40.50 | -19.67% |
| February, 2027 | $37.15 | $33.68 | $37.22 | -12.40% |
| March, 2027 | $47.87 | $37.16 | $48.89 | +12.88% |
| April, 2027 | $47.82 | $46.92 | $52.10 | +12.75% |
| May, 2027 | $46.63 | $46.10 | $48.85 | +9.96% |
| June, 2027 | $47.92 | $45.26 | $48.73 | +12.99% |
| July, 2027 | $48.18 | $47.20 | $50.80 | +13.60% |
| August, 2027 | $44.86 | $44.58 | $49.28 | +5.79% |
| September, 2027 | $45.05 | $42.78 | $47.13 | +6.23% |
| October, 2027 | $47.09 | $44.55 | $47.19 | +11.03% |
| November, 2027 | $52.01 | $46.23 | $53.62 | +22.65% |
| December, 2027 | $53.34 | $50.94 | $56.04 | +25.78% |
Taro Pharmaceutical Industries Stock (TARO) Price Forecast for 2028
In 2028, Taro Pharmaceutical Industries (TARO) is projected to reach an average price of $45.62, with a high projection of $55.39 and a low estimate of $35.86. This indicates an +7.57% rise from the last price of $42.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $52.40 | $52.34 | $53.43 | +23.55% |
| February, 2028 | $52.53 | $50.82 | $52.60 | +23.85% |
| March, 2028 | $52.69 | $52.28 | $52.92 | +24.25% |
| April, 2028 | $52.08 | $51.33 | $53.15 | +22.80% |
| May, 2028 | $37.58 | $35.86 | $43.74 | -11.40% |
| June, 2028 | $42.73 | $36.93 | $45.41 | +0.75% |
| July, 2028 | $51.15 | $41.19 | $52.17 | +20.61% |
| August, 2028 | $50.28 | $49.40 | $55.39 | +18.55% |
| September, 2028 | $49.81 | $49.46 | $52.16 | +17.45% |
| October, 2028 | $51.25 | $48.58 | $52.06 | +20.85% |
| November, 2028 | $51.39 | $50.54 | $54.14 | +21.17% |
| December, 2028 | $46.92 | $46.47 | $51.45 | +10.64% |
Taro Pharmaceutical Industries Stock (TARO) Price Forecast for 2029
The 2029 price forecast for Taro Pharmaceutical Industries Stock (TARO) is $49.28 on average, with a high prediction of $59.47 and a low estimate of $39.10. This represents an +16.21% increase from the previous price of $42.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $49.82 | $46.15 | $50.51 | +17.47% |
| February, 2029 | $51.49 | $49.07 | $51.92 | +21.41% |
| March, 2029 | $55.06 | $51.17 | $57.03 | +29.83% |
| April, 2029 | $56.77 | $54.36 | $59.47 | +33.87% |
| May, 2029 | $55.87 | $55.72 | $56.86 | +31.74% |
| June, 2029 | $55.95 | $54.28 | $56.30 | +31.93% |
| July, 2029 | $56.17 | $55.76 | $56.40 | +32.45% |
| August, 2029 | $42.14 | $42.02 | $56.64 | -0.64% |
| September, 2029 | $40.83 | $39.10 | $43.30 | -3.73% |
| October, 2029 | $45.83 | $40.19 | $48.67 | +8.07% |
| November, 2029 | $57.24 | $44.46 | $58.29 | +34.97% |
| December, 2029 | $53.58 | $52.70 | $58.68 | +26.33% |
Taro Pharmaceutical Industries Stock (TARO) Price Forecast for 2030
Taro Pharmaceutical Industries Stock (TARO) is expected to reach an average price of $54.07 in 2030, with a high forecast of $62.89 and a low forecast of $45.25. This signifies an +27.50% surge from the last price of $42.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $52.05 | $51.97 | $55.48 | +22.74% |
| February, 2030 | $56.29 | $51.90 | $57.47 | +32.73% |
| March, 2030 | $54.74 | $53.88 | $56.90 | +29.07% |
| April, 2030 | $50.29 | $49.84 | $54.80 | +18.57% |
| May, 2030 | $53.20 | $49.52 | $53.89 | +25.45% |
| June, 2030 | $54.89 | $52.46 | $55.32 | +29.43% |
| July, 2030 | $58.54 | $54.57 | $60.44 | +38.02% |
| August, 2030 | $59.85 | $57.79 | $62.89 | +41.13% |
| September, 2030 | $59.32 | $59.17 | $60.24 | +39.87% |
| October, 2030 | $59.69 | $57.74 | $59.77 | +40.74% |
| November, 2030 | $59.82 | $59.24 | $59.91 | +41.06% |
| December, 2030 | $45.37 | $45.25 | $60.13 | +6.99% |
2.15%
1.84%
Cap:
|
Volume (24h):